Organoid Research Center, Institute of Translational Medicine, Shanghai University, Shanghai 200444, People's Republic of China.
National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai 200444, People's Republic of China.
Biofabrication. 2024 May 15;16(3). doi: 10.1088/1758-5090/ad467c.
Organoids have emerged as crucial platforms in tissue engineering and regenerative medicine but confront challenges in faithfully mimicking native tissue structures and functions. Bioprinting technologies offer a significant advancement, especially when combined with organoid bioinks-engineered formulations designed to encapsulate both the architectural and functional elements of specific tissues. This review provides a rigorous, focused examination of the evolution and impact of organoid bioprinting. It emphasizes the role of organoid bioinks that integrate key cellular components and microenvironmental cues to more accurately replicate native tissue complexity. Furthermore, this review anticipates a transformative landscape invigorated by the integration of artificial intelligence with bioprinting techniques. Such fusion promises to refine organoid bioink formulations and optimize bioprinting parameters, thus catalyzing unprecedented advancements in regenerative medicine. In summary, this review accentuates the pivotal role and transformative potential of organoid bioinks and bioprinting in advancing regenerative therapies, deepening our understanding of organ development, and clarifying disease mechanisms.
类器官已成为组织工程和再生医学中至关重要的平台,但在真实模拟天然组织结构和功能方面仍面临挑战。生物打印技术提供了重大的进展,尤其是与类器官生物墨水结合使用时,类器官生物墨水是专门设计用来封装特定组织的结构和功能元素的工程配方。本综述对类器官生物打印的发展和影响进行了严格、重点的考察。它强调了类器官生物墨水的作用,类器官生物墨水整合了关键的细胞成分和微环境线索,以更准确地复制天然组织的复杂性。此外,本综述预计人工智能与生物打印技术的融合将带来变革性的前景。这种融合有望改进类器官生物墨水配方和优化生物打印参数,从而推动再生医学的空前进展。总之,本综述强调了类器官生物墨水和生物打印在推进再生疗法、加深我们对器官发育的理解以及阐明疾病机制方面的关键作用和变革潜力。